We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
(+4.6%)
Cap. Flow
-$5.41B
Cap. Flow
% of AUM
-23.63%
Top 10 Holdings %
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$41.8M |
| 2 |
Apple
AAPL
|
+$35.4M |
| 3 |
Amazon
AMZN
|
+$34.6M |
| 4 |
AESC
The AES Corporation
AESC
|
+$30.3M |
| 5 |
Adobe
ADBE
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$236M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$25M |
| 4 |
Applied Materials
AMAT
|
+$22.1M |
| 5 |
Baxter International
BAX
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Financials | 8.11% |
| 3 | Healthcare | 7.32% |
| 4 | Consumer Discretionary | 6.91% |
| 5 | Communication Services | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.83T
| $847M | 3.7% |
3,006,056
+143,497
| +5% | +$41.8M |
|
|
2
Apple
AAPL
$4.72T
| $773M | 3.38% |
5,461,823
+240,441
| +5% | +$35.4M |
|
|
3
Amazon
AMZN
$2.51T
| $568M | 2.48% |
3,460,940
+200,360
| +6% | +$34.6M |
|
|
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $557M | 2.43% |
1,297,800
+461,800
| +55% | +$204M |
|
5
Meta Platforms (Facebook)
META
$1.54T
| $394M | 1.72% |
1,161,499
+53,002
| +5% | +$19.1M |
|
6
Alphabet (Google) Class A
GOOGL
$3.88T
| $372M | 1.62% |
2,780,760
+77,160
| +3% | +$10.5M |
|
|
7
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $296M | 1.29% |
690,021
-535,483
| -44% | -$236M |
|
8
NVIDIA
NVDA
$5.06T
| $268M | 1.17% |
12,943,740
-371,460
| -3% | -$7.71M |
|
9
PUT
Invesco QQQ Trust
QQQ
$460B
| $265M | 1.16% |
741,500
-302,500
| -29% | -$111M |
|
10
JPMorgan Chase
JPM
$930B
| $201M | 0.88% |
1,227,506
+63,011
| +5% | +$9.88M |
|
|
11
Alphabet (Google) Class C
GOOG
$3.88T
| $196M | 0.85% |
1,468,380
+110,780
| +8% | +$15.3M |
|
12
Bank of America
BAC
$430B
| $181M | 0.79% |
4,262,179
+474,772
| +13% | +$19.1M |
|
13
UnitedHealth
UNH
$385B
| $174M | 0.76% |
444,740
+10,847
| +2% | +$4.49M |
|
14
Visa
V
$669B
| $167M | 0.73% |
749,952
+49,371
| +7% | +$11.6M |
|
15
PUT
Tesla
TSLA
$1.2T
| $163M | 0.71% |
629,700
+1,200
| +0.2% | +$282K |
|
16
Salesforce
CRM
$129B
| $143M | 0.62% |
526,866
+62,636
| +13% | +$15.9M |
|
17
PUT
Sea Limited
SE
$60.9B
| $141M | 0.61% |
441,000
+147,000
| +50% | +$45.1M |
|
18
Walt Disney
DIS
$161B
| $131M | 0.57% |
771,979
+15,186
| +2% | +$2.71M |
|
19
Johnson & Johnson
JNJ
$624B
| $118M | 0.52% |
731,080
+48,943
| +7% | +$8.35M |
|
|
20
Applied Materials
AMAT
$447B
| $115M | 0.5% |
892,873
-162,446
| -15% | -$22.1M |
|
|
21
Adobe
ADBE
$84.3B
| $113M | 0.5% |
197,057
+40,696
| +26% | +$25.6M |
|
22
Home Depot
HD
$324B
| $113M | 0.49% |
344,058
+22,005
| +7% | +$7.23M |
|
23
Eli Lilly
LLY
$1.06T
| $106M | 0.46% |
458,346
-7,972
| -2% | -$1.97M |
|
24
PayPal
PYPL
$49.4B
| $106M | 0.46% |
406,157
+9,247
| +2% | +$2.62M |
|
25
Mastercard
MA
$469B
| $105M | 0.46% |
302,601
+15,908
| +6% | +$5.78M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.
- Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
- Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
- Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
- Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
- Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
- Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
- Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.
Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.